A carregar...
Denosumab for Treatment of Hypercalcemia of Malignancy
CONTEXT: Hypercalcemia of malignancy (HCM) in patients with advanced cancer is often caused by excessive osteoclast-mediated bone resorption. Patients may not respond to or may relapse after iv bisphosphonate therapy. OBJECTIVE: We investigated whether denosumab, a potent inhibitor of osteoclast-med...
Na minha lista:
Main Authors: | , , , , , , , , , , , , , , |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Endocrine Society
2014
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4154084/ https://ncbi.nlm.nih.gov/pubmed/24915117 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2014-1001 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|
A carregar...